Table 2.
PVE | PVL | Hypertrophy | |||||
---|---|---|---|---|---|---|---|
N | Volume increase | Morbidity | N | Volume increase | Morbidity | ||
Broering et al. 35 | 17 | 188 mL | 5.8% | 17 | 123 mL | 5.8% | PVE > PVL |
Aussilhou et al. 34 | 18 | 35% | NA | 17 | 38% | NA | PVE = PVL |
Capusotti et al. 95 | 31 | 53.4% | 3.2% | 17 | 43.1% | 0% | PVE = PVL |
Robles et al. 37 | 18 | 40% | NA | 20 | 30% | NA | PVE > PVL |
Van Lienden et al. 38 | 14 | 41.6% | NA | 7 | 8.1% | NA | PVE > PVL |
Abbreviations: PVE, portal vein embolization; PVL, portal vein ligation; NA, not available.